SDI Limited (AU:SDI)
ASX:SDI
Top Page
SDI Limited
(Sydney:SDI)
Select Model
Select Model
Rating:75Outperform
Price Target:
AU$1.50
▲(63.04% Upside)
Action:ReiteratedDate:03/24/26
The score is driven primarily by solid financial quality (strong margins, low leverage, and improved 2025 cash generation) and an attractive valuation (low P/E with a dividend). Technicals are supportive due to a strong uptrend, but a very high RSI signals overbought conditions that temper the overall rating.
Positive Factors
High gross margins
Sustained gross margins near 57–63% indicate durable pricing power and product differentiation in dental materials. Those margins support consistent earnings generation, enabling reinvestment in R&D, steady dividend capacity and resilience to moderate cost pressures over a multi-quarter horizon.
Negative Factors
Slowing revenue momentum
A rollover from modest growth to a small revenue decline suggests top-line vulnerability in key markets or channels. Sustained or worsening revenue stagnation would reduce scale benefits, constrain margin recovery and limit the firm's ability to invest in product development or distribution expansion.
Read all positive and negative factors
Positive Factors
Negative Factors
High gross margins
Sustained gross margins near 57–63% indicate durable pricing power and product differentiation in dental materials. Those margins support consistent earnings generation, enabling reinvestment in R&D, steady dividend capacity and resilience to moderate cost pressures over a multi-quarter horizon.
Read all positive factors
SDI Limited (SDI) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$148.58M
Dividend Yield3.7%
Average Volume (3M)69.13K
Price to Earnings (P/E)8.4
Beta (1Y)-0.32
Revenue Growth-0.74%
EPS Growth16.65%
CountryAU
Employees275
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)0.03
Shares Outstanding118,865,524
10 Day Avg. Volume9,034
30 Day Avg. Volume69,131
Financial Highlights & Ratios
PEG Ratio0.59
Price to Book (P/B)0.97
Price to Sales (P/S)0.90
P/FCF Ratio6.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.1
Revenue Forecast (FY)AU$115.90M
SDI Limited Business Overview & Revenue Model
Company Description
SDI Limited engages in the research and development, manufacture, and marketing of dental restorative materials, whitening systems, and other dental materials in Australia. It provides adhesives, alloys, cement, composites, etchants, glass ionomer...
How the Company Makes Money
A reliable, source-backed explanation of how SDI Limited (SDI) makes money (including revenue model, key revenue streams, and significant partnerships or factors contributing to earnings) is not available in the information provided. null...
SDI Limited Financial Statement Overview
Summary
Income Statement
67
Positive
Balance Sheet
78
Positive
Cash Flow
72
Positive
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 111.77M | 110.38M | 111.21M | 107.86M | 95.15M | 81.65M |
| Gross Profit | 71.35M | 69.38M | 69.04M | 61.27M | 53.11M | 50.25M |
| EBITDA | 20.62M | 18.36M | 20.96M | 15.73M | 14.76M | 16.84M |
| Net Income | 11.58M | 12.16M | 10.42M | 7.06M | 7.28M | 8.94M |
Balance Sheet | ||||||
| Total Assets | 135.84M | 141.20M | 140.66M | 133.31M | 102.07M | 98.40M |
| Cash, Cash Equivalents and Short-Term Investments | 4.56M | 8.98M | 6.28M | 6.02M | 7.01M | 10.56M |
| Total Debt | 17.33M | 17.38M | 24.78M | 25.60M | 2.02M | 1.57M |
| Total Liabilities | 32.40M | 38.52M | 46.69M | 45.39M | 18.34M | 18.62M |
| Stockholders Equity | 103.44M | 102.67M | 93.97M | 87.92M | 83.73M | 79.78M |
Cash Flow | ||||||
| Free Cash Flow | 10.90M | 15.12M | 4.03M | -21.42M | -61.00K | 8.64M |
| Operating Cash Flow | 14.58M | 19.19M | 14.33M | 13.06M | 4.27M | 12.69M |
| Investing Cash Flow | -3.97M | -4.17M | -8.78M | -33.41M | -4.25M | -3.95M |
| Financing Cash Flow | -10.90M | -12.05M | -5.33M | 19.20M | -3.49M | -4.18M |
SDI Limited Technical Analysis
Positive
0.92
Price Trends
1.08
Positive
1.02
Positive
0.94
Positive
Market Momentum
0.05
Positive
68.82
Neutral
30.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:SDI, the sentiment is Positive. The current price of 0.92 is below the 20-day moving average (MA) of 1.25, below the 50-day MA of 1.08, and below the 200-day MA of 0.94, indicating a neutral trend. The MACD of 0.05 indicates Positive momentum. The RSI at 68.82 is Neutral, neither overbought nor oversold. The STOCH value of 30.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:SDI.
SDI Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | AU$148.58M | 8.38 | 11.23% | 3.70% | -0.74% | 16.65% | |
63 Neutral | AU$125.54M | 7.70 | 14.03% | ― | 39.98% | -30.04% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | AU$127.13M | -3.64 | -725.04% | ― | 22.67% | ― | |
47 Neutral | AU$62.56M | -59.43 | -1.32% | ― | 7.38% | 82.39% | |
44 Neutral | AU$102.68M | -6.27 | -54.48% | ― | 34.20% | -23.90% | |
44 Neutral | AU$148.70M | -10.00 | -70.29% | ― | ― | -257.32% |
* Healthcare Sector Average
AU:SDI
SDI Limited
1.25
0.41
48.63%
AU:AHC
Austco Healthcare Limited
0.34
0.05
15.52%
AU:CYC
Cyclopharm Limited
0.85
-0.39
-31.45%
AU:TRJ
Trajan Group Holdings Ltd
0.41
-0.37
-47.44%
AU:DAI
Decidr AI Industries
0.40
-0.16
-28.18%
AU:EMV
EMvision Medical Devices Ltd.
1.60
-0.33
-17.10%
SDI Limited Corporate Events
SDI chairman trims stake but backs A$1.40-per-share scheme
Mar 25, 2026
SDI Limited has disclosed that its chairman, Jeffery James Cheetham, has sold 670,000 SDI shares for personal reasons via an indirect holding through a superannuation vehicle. Despite the sale, Cheetham remains the company’s largest sharehol...
SDI backs A$166m takeover by China’s Sinocera unit at hefty premium
Feb 27, 2026
SDI Limited has agreed to be acquired by Beijing Guoci Kebo Technology, a subsidiary of Shandong Sinocera Functional Material, through a scheme of arrangement under which SDI shareholders will receive A$1.40 in cash per share, valuing the equity a...
SDI Limited Issues Interim Report for Half-Year Ended 31 December 2025
Feb 27, 2026
SDI Limited has released its interim report for the half-year ended 31 December 2025, detailing commentary on its half-year results and providing the usual suite of consolidated financial statements, directors’ reports, and an independent au...
SDI lifts margins and maintains profit as amalgam sales decline
Jan 6, 2026
SDI Limited reported preliminary unaudited sales of $53.1 million for the half year to 31 December 2025, a 3.0% increase in Australian dollar terms but a 1.2% decline on a constant-currency basis, as strong growth of 11.9% in Australian direct exp...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.